Skip to search formSkip to main contentSkip to account menu

Traxoprodil

Known as: (Alpha-S,Beta-S)-4-Hydroxy-Alpha-(P-Hydroxyphenyl)-Beta-Methyl-4-Phenyl-1-Piperidineethanol, 1-Piperidineethanol, 4-Hydroxy-Alpha-(4-Hydroxyphenyl)-Beta-Methyl-4-Phenyl-, (S-(R*,R*))- 
National Institutes of Health

Related topics

Related topics

1 relation
traxoprodil mesylate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Brain networks in pharmacological fMRI of NMDA antagonists
In recent years network methods have gained great popularity in the analysis of resting state data obtained by functional… 
2018
2018
Mapping the central effects of (±)-ketamine and traxoprodil using pharmacological magnetic resonance imaging in awake rats
Major depressive disorder is a leading cause of disability globally. Improvements in the efficacy of antidepressant therapy are… 
2015
2015
Potencies and unblocking kinetic properties of antagonists at recombinant human NMDA receptors in a Xenopus oocytes model
N-methyl-d-aspartate (NMDA) receptor channels are implicated in a wide range of physiological and pathophysiological processes… 
2012
2012
Epilepsy nurse specialists are a vital resource
2010
2010
Pharmacokinetics and pharmacodynamics of ritodrine hydrochloride administered orally and intramuscularly to female healthy volunteers
Abstract Ritodrine hydrochloride ((R,S)–4-hydroxy-β-[1-[2-((4-hydroxyphenyl)ethyl]amino)ethyl]benzenemethanol, CAS 26652-09-5) is… 
2007
2007
Traxoprodil promising for resistant depression
  • 2007
  • Corpus ID: 195107547
2006
2006
Method of administration of (1s,s2) -1- (4 -hydroxyphenyl) -2- (4-hydr0xy-4-phenylpiperidin-1-yl) -1- propano (traxoprodil)
The present invention in one aspect is directed to a method for improving the bio-availability of (IS, 2S) -1- (4-hydroxyphenyl… 
2003
2003
Regio- and stereoselective hydroxylations with Sphingomonas sp. HXN-200
— IV — Sphingomonas sp. HXN-200 was found to be highly effective and regioselective for the hydroxylations of N-substituted… 
Review
1994
Review
1994
Glutamatergic drugs in Parkinson's disease.
1983
1983
Aprimate modelofparkinsonism: Selective destruction of dopaminergic neurons intheparscompacta ofthe substantia nigra byN-methyl-4-phenyl-
ABSTRACT A syndrome similar to idiopathic parkinsonismdeveloped after intravenous self-administration of an illicit… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)